Riskpilot← Back to searchSign inGet full accessMELHUS HELSEARTIKLER AS
ASActiveOrg 966094400Gimsbruvegen 4, 7224 MelhusRetail sale of medical and orthopaedic goods · NACE 4774Est. 19936 employees
Revenue 2025
NOK 8,3M
+9% vs 2024
EBITDA margin
3.6%
-50% vs 2024
Equity ratio
16.3%
Financial strength
Net profit 2025
NOK 126K
-75% vs 2024
| Revenue | NOK 8,3M | +9% |
| EBITDA | NOK 302K | -50% |
| Net profit | NOK 126K | -75% |
| Total assets | NOK 1,7M | +8% |
| Equity | NOK 272K | +86% |
| Employees | 6 | — |
Legal name
MELHUS HELSEARTIKLER AS
Org number
966094400
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9. februar 1993
Share capital
—
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Address
Gimsbruvegen 4, 7224 Melhus
Phone
+4772871150
Email
postmaster@melhushelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 121 | 7 442 | 6 826 | 7 597 | 8 283 |
| Staff expenses | −1 466 | −1 788 | −1 512 | −1 281 | −1 698 |
| EBITDA | 1 075 | −275 | −24 | 603 | 302 |
| Depreciation & amort. | −3 | −0 | −0 | −22 | −70 |
| EBIT | 1 073 | −275 | −24 | 581 | 232 |
| Net financials | −16 | −1 740 | −35 | −62 | −45 |
| Profit before tax | 1 057 | −2 015 | −58 | 519 | 187 |
| Tax | 241 | −56 | 65 | 14 | 61 |
| Net profit | 816 | −1 960 | −123 | 505 | 126 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 220 | 934 | 1 245 | 1 548 | 1 673 |
| Equity | 1 724 | −235 | −358 | 147 | 272 |
| Long-term debt | 0 | 0 | 0 | 264 | 243 |
| Short-term debt | 1 496 | 1 169 | 1 603 | 1 136 | 1 158 |
| Total debt | 1 496 | 1 169 | 1 603 | 1 401 | 1 400 |
EBITDA margin
3.6%
This company
15.8%
Market median
-77% vs market
20212025
Equity ratio
16.3%
This company
38.2%
Market median
-57% vs market
20212025
Return on equity
46.1%
This company
18.4%
Market median
+151% vs market
20212025
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20212025
Asset turnover
4.95×
This company
1.12×
Market median
+342% vs market
20212025
Debt / equity
5.14×
This company
0.62×
Market median
-729% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LT Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2019 – 2019 | |
| Board of Directors | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lån Holding As
MELHUS HELSEARTIKLER AS Board members of MELHUS HELSEARTIKLER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linn Therese Haugen Storvold | Chief Executive Officer | 0 companies |
| Eva Schanche Nilsen | Board of Directors | 0 companies |
| Johanne Myren Benberg | Board of Directors | 0 companies |
| Lisa Nordbotn | Chairman | 0 companies |